What Researchers Did
Researchers compared topical wound oxygen (TWO2) with conventional compression dressings (CCDs) in 132 patients with refractory nonhealing venous ulcers over 12 weeks.
What They Found
At 12 weeks, topical wound oxygen (TWO2) led to a 96% mean ulcer size reduction and 76% complete healing, compared to 61% reduction and 46% healing with conventional compression dressings (CCDs). The median time to healing was 57 days for TWO2 versus 107 days for CCDs, and recurrence rates after 36 months were significantly lower with TWO2 (3 of 51 healed ulcers) compared to CCDs (14 of 30 healed ulcers).
What This Means for Canadian Patients
Canadian patients with refractory nonhealing venous ulcers might benefit from topical wound oxygen therapy, potentially experiencing faster healing and reduced recurrence. This could lead to improved quality of life and fewer complications associated with chronic wounds.
Canadian Relevance
This study did not include Canadian participants or researchers, so its direct Canadian relevance is not established.
Study Limitations
The study's findings may be limited by its specific patient population and potential single-center design, which could affect generalizability.